Diligence memo · auto-generated · as of July 2, 2026
GLYSENS Inc
GLYSENS Inc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
GLYSENS Inc operates in Other Health Care, based in SAN DIEGO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
GLYSENS Inc has raised $20M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $20M on 2015-12-21.
Most recent recorded round closed around 2015-12-21.
Valuation (modeled)modeled
Provath models GLYSENS Inc at approximately $443M (range $47M–$1.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.00× the median modeled value of Series B Other Health Care companies in 2013–2015 (85 peers) — value vs value, same stage and era. Within the normal band (100% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 10.5 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 84% of Other Health Care peers (5377 compared).
Modeled value ranks above 93% of those peers.
Closest niche peers: Drynachan, Llc, Vistria SHC Holdings, LLC, Ebh Holding Company, Inc., Orthopediatrics Corp, Assurerx Health, Inc.
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.